| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.39 | 4e-07 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.38 | 3e-06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.38 | 3e-06 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |